动态对比增强MRI对中央性软骨肿瘤诊断与随访价值的评估
回顾性/连续性纳入97例中央性软骨肿瘤患者,评估动态对比增强MRI的诊断与随访价值。结果显示增强环厚度>1.2 mm识别高级别软骨肉瘤的敏感度为100%、特异度为64%;全肿瘤相对最大强化与绝对生长率显著相关(ρ=0.75,p<0.001)。
要点
- 增强环厚度>1.2 mm识别高级别软骨肉瘤的敏感度为100%、特异度为64%,AUC为0.89。
- 全肿瘤相对最大强化与绝对生长率显著相关(ρ=0.75,p<0.001)。
- 相对最大强化<1的病变随访中保持稳定或消退,平均变化-0.1±0.3 ml/年。
核心结论
- 增强环厚度>1.2 mm对检测高级别软骨肉瘤具有高敏感度。
- 全肿瘤相对最大强化越高,中央性软骨肿瘤的生长率越高。
研究设计与样本
- 回顾性/连续性纳入97例中央性软骨肿瘤患者(44±11岁,31名男性),于比利时根特大学医院2003—2021年纳入,经组织病理学证实和/或随访>2年(5±3年)。
- 计算增强环厚度及全肿瘤动态对比增强MRI参数,并计算肿瘤体积以评估肿瘤生长。
- 比较内生软骨瘤、非典型软骨性肿瘤、高级别软骨肉瘤及随访中有无生长的肿瘤之间的显著差异,并分析ROC曲线。
关键影像表现/征象
- 高级别软骨肉瘤与其他组之间增强环厚度存在显著差异(p=0.015)。
诊断标准与关键数值
- 增强环厚度ROC曲线AUC为0.89,截断值1.2 mm,识别高级别软骨肉瘤的敏感度为100%、特异度为64%。
临床应用与阅片要点
- 增强环厚度>1.2 mm对识别高级别软骨肉瘤具有高敏感度。
- 全肿瘤相对最大强化<1的病变随访中保持稳定或消退(平均-0.1±0.3 ml/年)。
- 全肿瘤相对最大强化在1~2之间的病变显示轻度生长(平均+0.2±0.2 ml/年)。
- 全肿瘤相对最大强化>2的病变生长率最高(平均0.4±0.2 ml/年)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the value of (dynamic) contrast-enhanced MRI for the diagnosis and follow-up of central cartilage tumors (CCT) of the proximal humerus, distal femur and proximal tibia.
MATERIALS & METHODS: 97 patients (44 ± 11 years, 31men) with a CCT (histopathologically proven and/or > 2 years follow-up (5 ± 3 years)) were retrospectively/consecutively included at the Ghent University Hospital (Belgium, 2003-2021). Thickness of the enhancing rim and dynamic contrast-enhanced MRI parameters of the entire tumor were calculated. Tumor volumes were calculated to assess tumor growth. Significant differences between enchondromas, atypical cartilaginous tumors, high-grade chondrosarcomas, tumors with and without growth at follow-up were evaluated and ROC-curves were analyzed.
RESULTS: A significant difference (p = 0.015) existed in enhancing rim thickness between high-grade chondrosarcomas and other groups. A ROC-curve with an AUC of 0.89 and cut-off value of 1.2 mm had a sensitivity of 100 % and a specificity of 64 % to identify high-grade chondrosarcomas. A significant correlation was found between the relative maximal enhancement (Rel-Emax) of the whole tumor compared to muscle and the absolute growth rate (ρ = 0.75, p < 0.001). Lesions with a Rel-Emax < 1 remained stable or showed regression during follow-up (mean -0.1 ± 0.3 ml/year). Lesions with a Rel-Emax between 1 and 2 showed little growth (mean + 0.2 ± 0.2 ml/year), and lesions with a Rel-Emax > 2 had the highest growth rate (mean 0.4 ± 0.2 ml/year).
CONCLUSION: A thick enhancing rim > 1.2 mm has a high sensitivity to detect high-grade chondrosarcomas. The higher the Rel-Emax of the whole tumor compared to muscle, the higher the growth rate of a CCT.
引用
- Lejoly M, Den Berghe TV, Delbare F, et al. Evaluation of the value of dynamic contrast-enhanced MRI for the diagnosis and follow-up of central cartilage tumors. Eur J Radiol. 2024. PMID: 39637581. doi:10.1016/j.ejrad.2024.111860
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。